[On electrorheographic objectivization of the long term effect of a retarding type of beta-pyridine carbonic acid].
D001161:Arteriosclerosis / Q000188:drug therapy*; D001795:Blood Pressure Determination; D005260:Female; D006334:Heart Function Tests; D006801:Humans; D008297:Male; D009536:Niacinamide / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D012212:Rheology
D011725:Pyridines; D009536:Niacinamide
Zur elektrorheographischen Objektivierung der Langzeitwirkung einer Retard-Form von Beta-Pyridinkarbonsäure.